Shet Anita, De Costa Ayesha, Kumarasamy N, Rodrigues Rashmi, Rewari Bharat Bhusan, Ashorn Per, Eriksson Bo, Diwan Vinod
Department of Pediatrics, St John's Medical College Hospital, Bangalore 560034, India Department of Public Health Sciences, Karolinska Institute, Stockholm 17177, Sweden.
Department of Public Health Sciences, Karolinska Institute, Stockholm 17177, Sweden
BMJ. 2014 Oct 24;349:g5978. doi: 10.1136/bmj.g5978.
OBJECTIVE: To assess whether customised mobile phone reminders would improve adherence to therapy and thus decrease virological failure among HIV infected patients starting antiretroviral treatment (ART). DESIGN: Randomised controlled trial among HIV infected patients initiating antiretroviral treatment. SETTING: Three diverse healthcare delivery settings in south India: two ambulatory clinics within the Indian national programme and one private HIV healthcare clinic. PARTICIPANTS: 631 HIV infected, ART naïve, adult patients eligible to initiate first line ART were randomly assigned to mobile phone intervention (n=315) or standard care (n=316) and followed for 96 weeks.. INTERVENTION: The intervention consisted of customised, interactive, automated voice reminders, and a pictorial message that were sent weekly to the patients' mobile phones for the duration of the study. MAIN OUTCOME MEASURES: The primary outcome was time to virological failure (viral load >400 copies/mL on two consecutive measurements). Secondary outcomes included ART adherence measured by pill count, death rate, and attrition rate. Suboptimal adherence was defined as mean adherence <95%. RESULTS: Using an intention-to-treat approach we found no observed difference in time to virological failure between the allocation groups: failures in the intervention and standard care arms were 49/315 (15.6%) and 49/316 (15.5%) respectively (unadjusted hazard ratio 0.98, 95% confidence interval 0.67 to 1.47, P=0.95). The rate of virological failure in the intervention and standard care groups were 10.52 and 10.73 per 100 person years respectively. Comparison of suboptimal adherence was similar between both groups (unadjusted incidence rate ratio 1.24, 95% CI 0.93 to 1.65, P=0.14). Incidence proportion of patients with suboptimal adherence was 81/300 (27.0%) in the intervention arm and 65/299 (21.7%) in the standard care arm. The results of analyses adjusted for potential confounders were similar, indicating no significant difference between the allocation groups. Other secondary outcomes such as death and attrition rates, and subgroup analysis also showed comparable results across allocation groups. CONCLUSIONS: In this multicentre randomised controlled trial among ART naïve patients initiating first line ART within the Indian national programme, we found no significant effect of the mobile phone intervention on either time to virological failure or ART adherence at the end of two years of therapy.Trial registration Current Controlled Trials ISRCTN79261738.
目的:评估定制的手机提醒是否会提高接受抗逆转录病毒治疗(ART)的HIV感染患者对治疗的依从性,从而降低病毒学失败率。 设计:对开始接受抗逆转录病毒治疗的HIV感染患者进行随机对照试验。 设置:印度南部三个不同的医疗服务机构:印度国家项目中的两家门诊诊所和一家私立HIV医疗诊所。 参与者:631名符合开始一线抗逆转录病毒治疗条件、未接受过抗逆转录病毒治疗的HIV感染成年患者被随机分配到手机干预组(n = 315)或标准治疗组(n = 316),并随访96周。 干预措施:干预措施包括定制的、交互式的自动语音提醒,以及在研究期间每周发送到患者手机上的图片信息。 主要观察指标:主要结局是病毒学失败时间(连续两次测量病毒载量>400拷贝/mL)。次要结局包括通过药丸计数测量的抗逆转录病毒治疗依从性、死亡率和损耗率。依从性欠佳定义为平均依从性<95%。 结果:采用意向性分析方法,我们发现各分配组之间在病毒学失败时间上没有观察到差异:干预组和标准治疗组的失败率分别为49/315(15.6%)和49/316(15.5%)(未调整风险比0.98,95%置信区间0.67至1.47,P = 0.95)。干预组和标准治疗组的病毒学失败率分别为每100人年10.52和10.73。两组之间依从性欠佳的比较相似(未调整发病率比1.24,95% CI 0.93至1.65,P = 0.14)。干预组依从性欠佳患者的发病比例为81/300(27.0%),标准治疗组为65/299(21.7%)。对潜在混杂因素进行调整后的分析结果相似,表明各分配组之间没有显著差异。其他次要结局,如死亡率和损耗率,以及亚组分析在各分配组之间也显示出可比的结果。 结论:在这项针对印度国家项目中开始一线抗逆转录病毒治疗的未接受过抗逆转录病毒治疗患者的多中心随机对照试验中,我们发现手机干预对两年治疗结束时的病毒学失败时间或抗逆转录病毒治疗依从性均无显著影响。试验注册 当代受控试验ISRCTN79261738。
Cochrane Database Syst Rev. 2023-7-17
Front Reprod Health. 2023-2-27
Explor Res Clin Soc Pharm. 2021-3-31
J Clin Epidemiol. 2013-11-22
N Engl J Med. 2013-11-7
Open AIDS J. 2013-8-13
Indian J Community Med. 2013-4
J Assoc Physicians India. 2012-12